IL-27, a novel heterodimeric cytokine produced by antigen-presenting cells, signals through the T cell cytokine receptor (TCCR) /WSX-1 expressed on naïve CD4 ؉ T cells and natural killer cells. TCCR /WSX-1 deficiency results in delayed T helper type 1 (TH1) development through an unresolved mechanism. We report here that IL-27 stimulation in developing murine T helper cells potently induces the expression of the major T H 1-specific transcription factor T-bet and its downstream target IL-12R ␤2, independently of IFN␥. In addition, IL-27 suppresses basal expression of GATA-3, the critical T H2-specific transcription factor that inhibits TH1 development by down-regulating signal transducer and activator of transcription (Stat) 4. IL-27 signaling through TCCR /WSX-1 induces phosphorylation of Stat1, Stat3, Stat4, and Stat5. Stat1 is required for suppression of GATA-3, but T-bet induction by IL-27 can also be mediated through a Stat1-independent pathway. Despite its T H1-like signaling profile, IL-27 is not sufficient to drive the differentiation of CD4 ؉ T cells into IFN␥-producing cells. Similarly, IL-27 induces T-bet expression in primary natural killer cells, but this does not result in an increase of IFN␥ production or cytotoxic activity. Therefore, although IL-27 is unable to drive IFN␥ production on its own, it plays an important role in the early steps of T H1 commitment by contributing in a paracrine manner to the control of IL-12 responsiveness.
T he differentiation of naïve CD4
ϩ T cells into T helper (T H ) type 1 (T H 1) or T H 2 effector cells is a critical process of the adaptive immune responses. T H 1 cells produce IFN␥ and promote cellular immunity, which is critical to control infections by intracellular pathogens. In contrast, T H 2 effector cells produce IL-4, IL-5, and IL-13 and promote humoral immunity, allergic reactions, and resistance to helmintic infections (1) (2) (3) . Many factors influence the differentiation process of CD4 ϩ T cells into T H 1 or T H 2 effector cells, including the dose of antigen, strength of signal through the T cell receptor, and costimulation, but cytokines have emerged as key determinants of the outcome (4) . IL-12 promotes T H 1 development by means of a signaling pathway that involves activation of signal transducer and activator of transcription (Stat) 4 (5). IL-4 induces Stat6 activation and drives naïve CD4 ϩ T cells down a T H 2 differentiation pathway. In addition, transcription factors playing causal roles in the establishment of gene expression programs specific for T H 1 and T H 2 cells have been identified. The T-box transcription factor T-bet was shown to play a central role in T H 1 cell development (6, 7) . An important function of T-bet is to maintain expression of the IL-12 receptor (IL-12R) ␤2 chain after activation of CD4 ϩ T cells (7) (8) (9) . In contrast, the zinc-finger transcription factor GATA-3 is crucial for inducing key attributes of T H 2 cells (10-13). GATA-3 also inhibits T H 1 development through suppression of IL-12R ␤2 and Stat4 expression, leading to the loss of IL-12 signaling (12, 14) .
T cell cytokine receptor (TCCR)
/WSX-1 is a type I cytokine receptor that was identified on the basis of sequence homology with gp130 and the IL-12R ␤2 chain (15, 16 . A product of activated antigen-presenting cells, IL-27 is formed by the association of EBI3, an IL-12p40-related polypeptide, and p28, a protein related to IL-12p35. IL-27 promotes the growth of naïve CD4 ϩ T cells and was suggested to play a role in the differentiation of T H 1 cells in vitro (18) .
We sought to further define the mechanisms by which IL-27 can influence the differentiation of T H cells. As a first step, we analyzed the signaling pathways that are activated by IL-27. We next evaluated the consequences of IL-27 stimulation on the expression of T-bet, GATA-3, and IL-12R ␤2, and the production of IFN␥ and IL-4 by T H cells. Finally, we examined the effects of IL-27 stimulation on NK cells, which express the TCCR /WSX-1 chain of the IL-27 receptor.
Methods
Mice, Primary Cells, Cytokines, and Antibodies. TCCR Ϫ/Ϫ and TCCR ϩ/ϩ mice in C57BL͞6 background (backcross 12) were bred in pathogen-free facilities at Genentech (16) . Stat1 Ϫ/Ϫ mice in 129Sv͞Ev background and 129Sv͞Ev (Stat1 ϩ/ϩ ) mice were purchased from Taconic Transgenics (Oxnard, CA).
Murine mononuclear cells were isolated from total splenocytes on a density gradient (Lympholyte, Cedarlane Laboratories). Primary CD4 ϩ T cells and NK cells were purified from splenic mononuclear cells by magnetic cell sorting with a Mouse CD4 ϩ T Cell Isolation Kit or anti-DX5 microbeads (Miltenyi Biotec, Auburn, CA). Purity of sorted cells was verified by fluorescence-activated cell sorting (FACS) analysis and ranged from 92% to 95% for CD4 ϩ T cells and from 60% to 70% for DX5 ϩ NK cells. Contamination of purified DX5 ϩ NK cells with CD4 ϩ T cells was Ͻ3.8%.
Human peripheral blood mononuclear cells from healthy donors were purified by density gradient (Lymphocyte Separation Medium, ICN).
Recombinant murine IL-2 (mIL-2), mIL-12, mIL-4, and human IL-15 (hIL-15) were purchased from R & D Systems. To produce mIL-27 and hIL-27, we constructed a plasmid with two cytomegalovirus promoter-driven expression cassettes. The first cassette contained murine or human p28 with a C-terminal gD-tag, and C-terminally FLAG-tagged murine or human EBI3 was cloned into the second cassette. These plasmids were transfected into mammalian cells, and recombinant mIL-27 or hIL-27 was purified from the supernatants.
Neutralizing antibodies against mIL-12, murine IFN␥, mIL-4, and mIL-2 were purchased from R & D Systems, and antimCD3 and mCD28 antibodies were from Pharmingen. Anti-Stat1 antibodies for immunoprecipitation (ATO-2F5) and for Western blot (ATO-1D6) were provided by R. D. Schreiber (Washington University, St. Louis). Anti-phosphoStat1 (Tyr-701), phosphoStat3 (Tyr-705), Stat3, phosphoStat5 (Tyr-694), and phosphoStat6 (Tyr-641) antibodies were from Cell Signaling Technology. Anti-Stat4 (C-20 sc-486) and Stat5b (C-17 sc-835) were purchased from Santa Cruz Biotechnology. AntiphosphoStat4 (Tyr-693) was from Zymed.
Antibodies used for FACS analysis were purchased from Pharmingen. . Cells were expanded on day 3 in IL-2-containing complete medium. On day 6 or 7, cells were collected, washed, and seeded at 10 6 cells per ml in 48-well plates coated with anti-mCD3 antibody (5 g͞ml).
Analysis of Stat
For proliferation assays, murine CD4 ϩ T cells were seeded at 8 ϫ 10 4 cells per well in 96-well plates coated with anti-mCD3 (5 g͞ml) and anti-CD28 (1 g͞ml) antibodies, in complete medium containing anti-mIL-2 antibodies (7.5 g͞ml), with or without mIL-27 (200 ng͞ml).
Murine DX5 ϩ NK cells were seeded in 48-well plates at 0.6 to 1 ϫ 10 6 per ml in complete medium supplemented with cytokines (200 ng͞ml mIL-27, 20 ng͞ml mIL-12, or 20 ng͞ml hIL-15).
Human peripheral blood mononuclear cells were seeded in 24-well plates at 10 6 cells per ml in complete medium (without 2-mercaptoethanol) supplemented with cytokines (200 ng͞ml hIL-27 or 100 ng͞ml hIL-15). Cells were collected and counted on day 7, and percentages of NK cells (CD3 Ϫ ͞CD56 ϩ ) at the start and at the end of the culture were determined by FACS analysis.
Real-Time RT-PCR. Total RNA was isolated with the RNeasy Mini kit and submitted to RNase-free DNase I digestion (Qiagen). TaqMan quantitative RT-PCR using a Sequence Detector 7700 instrument was carried out according to the manufacturer's instructions (Applied Biosystems). For each sample, duplicate test reactions and a control reaction into which no reverse transcriptase had been added were analyzed for expression of T-bet, IL-12R ␤2, or GATA-3 mRNAs and a housekeeper mRNA, rpl-19. No signal was observed in the control reactions. Expression levels are calculated by comparison to serial dilutions of a standard RNA and are expressed as nanograms of standard RNA, by using SEQUENCE DETECTOR software (Applied Biosystems). Arbitrary expression units were calculated by dividing T-bet, IL-12R ␤2, or GATA-3 expression by rpl-19 expression. Probes and primers were designed with PRIMER EXPRESS software (Applied Biosystems). The primer triplets were 5Ј-CCAGAGCGGCAAGTGGG-3Ј (sense), 5Ј-CATATAAGCG-GT TCCCTGGC-3Ј (antisense), and 5Ј-TGCTGCCT T-CTGCCTTTCCACACTG-3Ј (probe) for mouse T-bet; 5Ј-CAAGCATTTGCATCGCTATCA-3Ј (sense), 5Ј-AATGC-CTTTTGCCGGAAGT-3Ј (antisense), and 5Ј-ACGAATT-GAGAACGTGCCCACCGT-3Ј (probe) for mouse IL-12R ␤2; 5Ј-CCTACCGGGTTCGGATGTAA-3Ј (sense), 5Ј-CACA-CACTCCCTGCCTTCTGT-3Ј (antisense), and 5Ј-TCGAGGC-CCAAGGCACGATCC-3Ј (probe) for mouse GATA-3; and 5Ј-ATCCGCAAGCCTGTGACTGT-3Ј (sense), 5Ј-TCGGGC-CAGGGTGT T T T T-3Ј (antisense), and 5Ј-T TCCCGG-GCTCGTTGCCG-3Ј (probe) for mouse rpl-19. 
Results

IL-27
Activates Stat1, but also Stat3, Stat4, and Stat5. Cytokines that bind to cytokine receptors of the type I family transduce their signal through the Janus kinase͞Stat pathway. To determine which Stat proteins are activated in response to IL-27 binding to its receptor, freshly isolated CD4 ϩ T cells from TCCR ϩ/ϩ and TCCR Ϫ/Ϫ mice were treated for 15 min with 200 ng͞ml mIL-27. We subsequently detected phosphorylation of Stat proteins by immunoprecipitation and͞or Western blot with anti-phosphorylated Stat antibodies (Fig. 1) . IL-27 strongly induces the phosphorylation of Stat1, -3, and -5, and, to a lesser extent, Stat4. IL-27 does not induce Stat6 phosphorylation. No phosphorylation of Stat proteins was observed in TCCR Ϫ/Ϫ cells in response to IL-27, indicating that TCCR is an essential component of the IL-27 receptor with regard to activation of Stat proteins.
IL-27 Induces T-bet and IL-12R ␤2 Expression and Suppresses GATA-3
Expression. To dissect the function of IL-27 in T H differentiation, we next tested whether IL-27 is able to induce expression of the T H 1-specific transcription factor T-bet under various conditions. Purified CD4 ϩ T cells from TCCR ϩ/ϩ and TCCR Ϫ/Ϫ mice were stimulated in the presence or absence of IL-27 with plate-bound anti-CD3 and anti-CD28 antibodies, in conditions that drive the differentiation process toward a T H 1 phenotype or a T H 2 phenotype, or in neutral conditions where IL-12, IFN␥, and IL-4 are all neutralized by antibodies. T-bet mRNA levels were measured by real-time RT-PCR ( Fig. 2A) . In the absence of IL-27, T-bet expression is induced 48 h after primary stimulation under T H 1 conditions as a result of autocrine IFN␥ signaling (8) , but it is not induced in neutral and T H 2 conditions, in which IFN␥ is efficiently neutralized by antibodies. IL-27 moderately increases the IFN␥-mediated T-bet induction that is observed in T H 1 conditions. More importantly, IL-27 induces T-bet expres-sion independent of IFN␥, in neutral and T H 2 conditions (32-fold inductions in TCCR ϩ/ϩ cells in the presence of IL-27 compared with the absence of IL-27). These inductions are specific for IL-27 because they are not observed in TCCR Ϫ/Ϫ CD4 ϩ cells. The maintenance of high levels of IL-12R ␤2 chain expression after T cell receptor activation is a consequence of T-bet mRNA induction and is important for maintaining IL-12 responsiveness in developing T H 1 cells (9, 19) . Therefore, we examined whether IL-27-mediated induction of T-bet also leads to high IL-12R ␤2 mRNA expression (Fig. 2B ). In the absence of IL-27, IL-12R ␤2 mRNA is induced 50-fold after 48 h of culture in T H 1 conditions. IL-27 stimulation further increases this induction in T H 1 conditions. IL-27 treatment is also able to strongly induce IL-12R ␤2 expression independent of IFN␥ in neutral conditions (150-fold induction in TCCR ϩ/ϩ cells in the presence of IL-27 compared with the absence of IL-27). During T H 2 development, IL-12R ␤2 expression is normally suppressed by GATA-3 (12) . Nevertheless, IL-27 treatment of developing T H 2 cells leads to high levels of IL-12R ␤2 expression (89-fold induction in the presence of IL-27 compared with its absence), although GATA-3 mRNA is strongly induced by IL-4 in these conditions (Fig. 2 B and C) . To further confirm the ability of IL-27 to induce the expression of IL-12R ␤2, we used FACS to examine surface expression of IL-12R ␤2 on activated CD4 ϩ T cells (Fig. 2D) . In the absence of IL-27, surface expression of the IL-12R ␤2 chain is observed on CD4 ϩ T cells activated in T H 1 conditions only. As predicted by the analysis of mRNA levels, IL-27 treatment further increases surface expression of IL-12R ␤2 in T H 1 conditions and strongly induces it in neutral and T H 2 conditions independently of IFN␥.
We next examined the effect of IL-27 on the expression of the transcription factor GATA-3, considered to be the master switch in T H 2 development (13). IL-12 and IFN␥ were previously shown to inhibit GATA-3 expression, and the complete suppression of GATA-3 during T H 1 development requires IL-12 (12) . As shown in Fig. 2C , GATA-3 expression is indeed completely suppressed in the presence of IL-12 (8.2-fold reduction in TCCR ϩ/ϩ cells 48 h after activation in T H 1 conditions compared with freshly isolated cells). In neutral conditions where IL-12, IFN␥, and IL-4 are all neutralized by antibodies, IL-27 strongly suppresses GATA-3 (10.6-fold reduction in TCCR ϩ/ϩ cells 48 h after activation compared with freshly isolated cells). This IL-27-mediated suppression of GATA-3 is comparable to that mediated by IL-12 and is not observed in TCCR Ϫ/Ϫ cells. Therefore, we conclude that IL-27 is able to repress GATA-3 expression independent of IFN␥ and IL-12. However, IL-27 is not able to significantly inhibit the high level of GATA-3 expression induced by IL-4 in T H 2 conditions (Fig. 2C ).
Stat1 Is Not Required for the IL-27-Mediated Induction of T-bet but Is
Required for the IL-27-Mediated Suppression of GATA-3. During in vitro T H 1 development, the induction of T-bet expression through IFN␥ was shown to depend strongly on Stat1 (8) . We therefore sought to determine whether the IL-27-dependent induction of T-bet was also mediated by Stat1. To this end, CD4 ϩ T cells isolated from Stat1 Ϫ/Ϫ mice or isogenic wild-type animals were stimulated with plate-bound anti-CD3 and anti-CD28 antibodies, and T-bet mRNA levels were measured 48 h after activation by real-time RT-PCR (Fig. 3A) . We found that, although T-bet levels were generally lower in Stat1 (Fig. 3A) , demonstrating the existence of a Stat1-independent pathway for the induction of T-bet in response to IL-27.
As shown in Fig. 3B , IL-27 treatment also induces IL-12R ␤2 expression in Stat1 Ϫ/Ϫ cells activated in neutral conditions. Therefore, the level of IL-27-mediated Stat1-independent induction of T-bet is sufficient to lead to increased IL-12R ␤2 expression.
We next evaluated the Stat1 dependence of the IL-27-mediated GATA-3 suppression. As shown in Fig. 3C , IL-27 is not able to suppress GATA-3 expression in CD4 ϩ T cells activated in neutral conditions if Stat1 is absent. Therefore, unlike IL-27-mediated T-bet induction, IL-27-mediated GATA-3 suppression depends is fully dependent on Stat1 activation. (Fig. 4) . In this classical in vitro differentiation experimental setting, the effect of IL-27 on the differentiation of CD4 ϩ T cells into IFN␥-producing cells can be distinguished from its effect on proliferation. In the absence of IL-12 (neutral and T H 2 conditions), the addition of IL-27 at the time of activation was not sufficient to significantly drive the differentiation of CD4 ϩ T cells into IFN␥-producing cells (Fig.  4A) . Noticeably, in these conditions, IL-27 is not able to synergize with IL-12 to increase the production of IFN␥ by T H 1 CD4 ϩ cells (Fig. 4A, T H 1 conditions) . The moderately reduced amount of IFN␥ secreted by T H 1 cells activated in the presence of IL-27 (Fig. 4A) was not repeatedly observed in other independent experiments and is not significant. IL-27 had no significant effect on IL-4 secretion (Fig. 4B) . (18) . We sought to determine whether Stat1 is implicated in transducing the IL-27 proliferative signal. As shown in Fig. 5 , activated Stat1-deficient CD4 ϩ T cells proliferate in response to IL-27 at least as well as their wild-type counterparts, thereby demonstrating that Stat1 is not required to mediate the IL-27-proliferative signal. On the contrary, Stat1 might mediate an antiproliferative signal in response to IL-27, similar to the antiproliferative effects that it mediates in response to IFNs (20) (21) (22) . Disruption of the IL-27-mediated activation of Stat1 could explain the observed hyperproliferation of TCCR / WSX-1 knockout splenocytes (17) .
IL-27 Alone Is Not Able to Induce the Differentiation of CD4
IL-27 Induces T-bet Expression in NK Cells but Does Not Increase NK
Effector Functions. The TCCR chain of the IL-27 receptor is expressed on NK cells (16) , and IL-27 was shown to synergize with IL-2 and IL-12 to increase IFN␥ production by human NK cells (18) . Therefore, we further investigated the effect of IL-27 on NK cells in vitro. IL-27, unlike IL-15, does not promote the proliferation of human or murine primary NK cells (Fig. 6A and data not shown).
Because T-bet expression is induced in NK cell lines by cytokines such as IL-15 and IL-21 (23), we examined whether IL-27 can induce T-bet expression in primary mouse NK cells. IL-27, like IL-12 and IL-15, induces T-bet expression in primary TCCR ϩ/ϩ NK cells, but not in TCCR Ϫ/Ϫ NK cells (Fig. 6B) . T-bet Ϫ/Ϫ NK cells were shown to produce reduced amounts of IFN␥ and have reduced spontaneous cytotoxic activities (6). However, IL-27-mediated induction of T-bet does not result in increased IFN␥ production by NK cells (Fig. 6C) , nor is it able to stimulate the cytolytic activity of primary NK cells (Fig. 6D) , in contrast to the direct effects of IL-12 and IL-15.
Discussion
The differentiation of CD4 ϩ T cells into distinct T H subsets is regulated by strongly polarizing cytokines such as IL-12 and IL-4, through signaling by means of Stat4 and Stat6, respectively (4). IL-27, a newly described member of the IL-12 family, has been implicated in T H 1 development (16-18, 24 ), but the exact mechanisms by which IL-27 influences the differentiation of T H cells are unclear.
To better define the roles of IL-27 in T H development, we examined the signaling pathways and, in particular, which Stat proteins are activated by IL-27 in primary CD4 ϩ T cells. We found that IL-27 stimulation leads to phosphorylation of Stat1, -3, -4, and -5. This pattern of Stat activation is more complex than that reported in a recent study in which, in an in vitro system testing direct interactions, Stat1 was the only Stat factor found to bind to the phosphorylated TCCR /WSX-1 chain of the IL-27 receptor (24) . However, like most other type I cytokine receptors, the functional IL-27 receptor is probably a heterodimer, as demonstrated by the inability of the TCCR /WSX-1 chain alone to transduce an IL-27 signal in transfected cells (ref. 18 and our unpublished data). Therefore, one possible interpretation of our data is that, upon stimulation with IL-27, Stat1 binds to the TCCR /WSX-1 chain of the IL-27 receptor, whereas binding and͞or activation of Stat3, -4, and -5 requires the second, as-yetunidentified chain of the IL-27 receptor. Only a few cytokine receptor chains of the type I family, including IL-12R ␤2 and IL-23 receptor, are able to activate Stat4. However, we did not observe any transduction of the IL-27 signal in cells transfected with TCCR /WSX-1 and IL-12R ␤2 or IL-23 receptor (data not shown), and the identity of the second chain of the IL-27 receptor remains to be determined.
T-bet, GATA-3, and IL-12R ␤2 represent key regulators of T H cell development. T-bet is a T H 1-specific transcription factor whose crucial importance for the development of T H 1 responses in vivo is underscored by the susceptibility of T-bet knockout mice to challenge with Leishmania major (25) . The expression of T-bet is induced readily in CD4 ϩ T cells by IFN␥ signaling mediated by Stat1 (8, 26) . However, induction of T-bet expression was observed in splenocytes derived from IFN␥ knockout mice (26) , implying the existence of IFN␥-independent mechanisms of T-bet induction. We demonstrate here that IL-27 provides an IFN␥-independent signal for the induction of T-bet in developing T H cells. Similarly, we show that IL-27 induces T-bet expression in primary NK cells. Although IFN␥-mediated induction of T-bet was shown to strongly depend on Stat1 activation (8), we show that T-bet can be induced in a Stat1-independent manner by IL-27 and under classical T H 1 culture conditions in which IL-12 induces IFN␥ secretion. The nature of the alternative signaling pathway implicated in the Stat1-independent induction of T-bet expression remains to be determined.
A critical downstream effect of T-bet expression in CD4 ϩ T cells consists in the induction of IL-12R ␤2 expression (8) and, consequently, acquisition of IL-12 responsiveness by developing T H cells. Consistently, IL-27-mediated induction of T-bet in CD4 ϩ T cells also leads to high levels of IL-12R ␤2 expression. GATA-3 is a transcription factor that regulates the expression of a broad array of T H 2 cytokines (10, 11) and represents a master switch for T H 2 development (13) . The expression of GATA-3 is induced rapidly by IL-4, increasing from a low basal level in naïve T cells to a high level in T H 2 cells (12) . Along with its direct role in promoting T H 2 development, GATA-3 inhibits T H 1 development by repressing IL-12R ␤2 expression (12) and, more importantly, by directly down-regulating Stat4 mRNA and protein levels (14) . Therefore, suppression of basal GATA-3 expression represents a critical event during T H 1 development, necessary to maintain IL-12 responsiveness of developing T H 1 cells. IL-12 and IFN␥ can suppress GATA-3 expression, and complete suppression requires both Stat1 and Stat4 (12) . We show here that IL-27 provides an alternative signal for GATA-3 suppression, which depends on Stat1.
T-bet induction in CD4 ϩ T cells leads to maintenance of high levels of IL-12R ␤2 expression, but the exact role of T-bet in inducing IFN␥ production by T H 1 cells is still unclear. Initial studies reported that retroviral overexpression of T-bet can induce IFN␥ secretion, independent of IL-12, by CD4 ϩ T cells restimulated with phorbol 12-myristate 13-acetate͞ionomycin (6, 7) . A later report showed that, in response to more physiological stimuli such as antigen-loaded antigen-presenting cells, retroviral T-bet expression is not able to induce IFN␥ production by CD4 ϩ T cells in the absence of IL-12 signaling (8). Our results obtained by stimulating CD4 ϩ T cells with anti-CD3 antibodies are in accordance with the latter study, because IL-27, which up-regulates T-bet expression, does not induce IFN␥ production in the absence of IL-12. Comparably, IL-27 can induce T-bet expression in primary NK cells but does not stimulate terminal effector functions such as IFN␥ production or cytotoxic activity. Our results supporting the inability of IL-27 to induce IFN␥ production on its own might appear contradictory to previous reports, in which IL-27 was initially shown to induce IFN␥ production by CD4 ϩ T cells in the absence of exogenous IL-12 (18) , or more recently to synergize with IL-12 to increase IFN␥ production (24) . One major caveat of these two studies is that both analyze IFN␥ production directly in the culture supernatants of CD4 ϩ T cells, 3 days after their activation. Because IL-27 potently induces the proliferation of activated naïve CD4 ϩ T cells (ref. 18 and Fig. 5) , and because neither IL-12 nor IFN␥ was neutralized in the culture conditions described, it is possible that the increase of IFN␥ production that was observed in the presence of IL-27 is exclusively due to the proliferative effect of this cytokine on CD4 ϩ T cells, which differentiate into IFN␥-producing cells in response to added or contaminating IL-12.
Although IL-27 does not drive the differentiation process of CD4 ϩ cells toward an IFN␥-secreting phenotype on its own, it certainly represents an important early trigger for T H 1 differentiation in vivo, as demonstrated by the increased initial susceptibility of TCCR /WSX-1 knockout mice to infection with intracellular pathogens (16, 17) . Our in vitro studies show that IL-27, an early product of activated antigen-presenting cells (18) , acts on naïve CD4 ϩ T cells by inducing IL-12 responsiveness by means of induction of T-bet and suppression of GATA-3. Therefore, at the time of activation of naïve CD4 ϩ T cell by antigen-presenting cells in vivo, IL-27 functions in a paracrine manner to establish IL-12 responsiveness of early developing T H cells, and consequently contributes to bias the T cell response toward a T H 1 outcome.
